Thyroid function in the critically ill newborn and child

Current Opinion in Pediatrics

Volumn 21, Issue 4, 2009, Pages 536-540

  Shih, Judy L ^a   Agus, Michael S D ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Critical care; Euthyroid sick syndromes; Pediatric ICUs; Thyroid hormones

Indexed keywords

LIOTHYRONINE; THYROXINE;

CHILD HEALTH; CRITICALLY ILL PATIENT; HEART SURGERY; HORMONE SUBSTITUTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LIOTHYRONINE BLOOD LEVEL; NEWBORN PERIOD; POSTOPERATIVE PERIOD; PREMATURITY; PRIORITY JOURNAL; REVIEW; THYROID FUNCTION; THYROID FUNCTION TEST; THYROID GLAND; THYROXINE BLOOD LEVEL;

ANIMALS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; CRITICAL ILLNESS; HUMANS; HYPOTHYROIDISM; INFANT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; THYROID GLAND; TREATMENT OUTCOME; TRIIODOTHYRONINE;

EID: 68949178508     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32832cbc12     Document Type: Review

References (62)

1. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000; 143:1-13.
2. Van den Berghe G, de Zegher F, Bouillon R. Clinical review 95: acute and prolonged critical illness as different neuroendocrine paradigms. J Clin Endocrinol Metab 1998; 83:1827-1834.
3. Menon K, Clarson C. Adrenal function in pediatric critical illness. Pediatr Crit CareMed 2002; 3:112-116.
4. Pizarro CF, Troster EJ, Damiani D, Carcillo JA. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med 2005; 33:855-859.
5. Sarthi M, Lodha R, Vivekanandhan S, Arora NK. Adrenal status in children with septic shock using low-dose stimulation test. Pediatr Crit Care Med 2007; 8:23-28.
6. Hebbar K, Rigby MR, Felner EI, etal. Neuroendocrine dysfunction in pediatric critical illness. Pediatr Crit Care Med 2009; 10:35-40.
7. Faber J, Kirkegaard C, Rasmussen B, et al. Pituitary-thyroid axis in critical illness. J Clin Endocrinol Metab 1987; 65:315-320.
8. Mitchell IM, Pollock JC, Jamieson MP, et al. The effects of cardiopulmonary bypass on thyroid function in infants weighing less than five kilograms. J Thorac Cardiovasc Surg 1992; 103:800-805.
9. Murzi B, Iervasi G, Masini S, etal. Thyroid hormones homeostasis in pediatric patients during and after cardiopulmonary bypass. Ann Thorac Surg 1995; 59:481-485.
10. Van den Berghe G, de Zegher F, Lauwers P. Dopamine suppresses pituitary function in infants and children. Crit Care Med 1994; 22:1747-1753.
11. Chopra IJ. Clinical review 86: euthyroid sick syndrome: is it a misnomer? J Clin Endocrinol Metab 1997; 82:329-334.
12. den Brinker M, Joosten KF, Visser TJ, et al. Euthyroid sick syndrome in meningococcal sepsis: the impact of peripheral thyroid hormone metabolism and binding proteins. J Clin Endocrinol Metab 2005; 90:5613-5620.
13. Keceligil HT, Kolbakir F, Adam B, etal. Thyroid hormone alterations during and after cardiopulmonary bypass. Cardiovasc Surg 1996; 4:617-622.
14. Iltumur K, Olmez G, Ariturk Z, et al. Clinical investigation: thyroid function test abnormalities in cardiac arrest associated with acute coronary syndrome. Crit Care 2005; 9:R416-R424.
15. Lynch BA, Brown DM, Herrington C, Braunlin E. Thyroid dysfunction after pediatric cardiac surgery. J Thorac Cardiovasc Surg 2004; 127:1509-1511.
16. Peeters RP, Wouters PJ, Kaptein E, etal. Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 2003; 88:3202-3211.
17. Vos RA, De Jong M, Bernard BF, et al. Impaired thyroxine and 3,5,30-triiodothyronine handling by rat hepatocytes in the presence of serum of patients with nonthyroidal illness. J Clin Endocrinol Metab 1995; 80:2364-2370.
18. Chopra IJ, Williams DE, Orgiazzi J, Solomon DH. Opposite effects of dexa-methasone on serum concentrations of 3,30, 50-triiodothyronine (reverse T3) and 3,305-triiodothyronine (T3). J Clin Endocrinol Metab 1975; 41:911-920.
19. Burger A, Dinichert D, Nicod P, et al. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest 1976; 58:255-259.
20. Sogol PB, Hershman JM, Reed AW, Dillmann WH. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 50-monodeiodination in rats. Endocrinology 1983; 113:1464-1469.
21. van der Poll T, Romijn JA, Wiersinga WM, Sauerwein HP. Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 1990; 71:1567-1572.
22. Stouthard JM, van der Poll T, Endert E, et al. Effects of acute and chronic interleukin-6 administration on thyroid hormone metabolism in humans. J Clin Endocrinol Metab 1994; 79:1342-1346.
23. Corssmit EP, Heyligenberg R, Endert E, et al. Acute effects of interferon-alpha administration on thyroid hormone metabolism in healthy men. J Clin Endocrinol Metab 1995; 80:3140-3144.
24. NagayaT, Fujieda M, Otsuka G, et al. A potential role of activated NF-kappaB in the pathogenesis of euthyroid sick syndrome. J Clin Invest 2000; 106:393-402.
25. Chopra IJ, Huang TS, Beredo A, et al. Evidence for an inhibitor of extrathyr-oidal conversion of thyroxine to 3,5,30-triiodothyronine in sera of patients with nonthyroidal illnesses. J Clin Endocrinol Metab 1985; 60:666-672.
26. Davidson MB, Chopra IJ. Effect of carbohydrate and noncarbohydrate sources of calories on plasma 3,5,30-triiodothyronine concentrations in man. J Clin Endocrinol Metab 1979; 48:577-581.
27. Slag MF, Morley JE, Elson MK, et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981; 245:43-45.
28. Jirasakuldech B, Schussler GC, Yap MG, et al. A characteristic serpin cleavage product of thyroxine-binding globulin appears in sepsis sera. J Clin Endocrinol Metab 2000; 85:3996-3999.
29. Fisher DA. Thyroid function and dysfunction in premature infants. Pediatr Endocrinol Rev 2007; 4:317-328.
30. Fisher DA. Thyroid system immaturities in very low birth weight premature infants. Semin Perinatol 2008; 32:387-397.
31. Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996; 334:821-827.
32. Lucas A, Morley R, Fewtrell MS. Low triiodothyronine concentration in preterm infants and subsequent intelligence quotient (IQ) at 8 year follow up. BMJ 1996; 312:1132-1133; discussion 3-4.
33. Den Ouden AL, Kok JH, Verkerk PH, et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996; 39:142-145.
34. Carrascosa A, Ruiz-Cuevas P, Clemente M, et al. Thyroid function in 76 sick preterm infants 30-36 weeks: results from a longitudinal study. J Pediatr Endocrinol Metab 2008; 21:237-243.
35. Williams FL, Ogston SA, van Toor H, et al. Serum thyroid hormones in preterm infants: associations with postnatal illnesses and drug usage. J Clin Endocrinol Metab 2005; 90:5954-5963.
36. Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev 2001; 22:240-254.
37. Buimer M, van Wassenaer AG, Kok JH. Postnatal administration of dexa-methasone for weaning off the ventilator affects thyroid function. Neonatology 2008; 94:164-169.
38. Verrotti A, Laus M, Scardapane A, et al. Thyroid hormones in children with epilepsy during long-term administration of carbamazepine and valproate. Eur J Endocrinol 2009; 160:81-86.
39. Holland FW 2nd, Brown PS Jr, Weintraub BD, Clark RE. Cardiopulmonary bypass and thyroid function: a 'euthyroid sick syndrome'. Ann Thorac Surg 1991; 52:46-50.
40. Allen DB, Dietrich KA, Zimmerman JJ. Thyroid hormone metabolism and level of illness severity in pediatric cardiac surgery patients. J Pediatr 1989; 114:59-62.
41. Bettendorf M, Schmidt KG, Tiefenbacher U, et al. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res 1997; 41: 375-379.
42. Ross OC, Petros A. The sick euthyroid syndrome in paediatric cardiac surgery patients. Intensive Care Med 2001; 27:1124-1132.
43. Dagan O, Vidne B, Josefsberg Z, et al. Relationship between changes in thyroid hormone level and severity of the postoperative course in neonates undergoing open-heart surgery. Paediatr Anaesth 2006; 16:538-542.
44. Brent GA, Hershman JM. Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. J Clin Endocrinol Metab 1986; 63:1-8.
45. van Wassenaer AG, Kok JH, de Vijlder JJ, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997; 336:21-26.
46. Klemperer JD, Klein I, Gomez M, et al. Thyroid hormone treatment after coronary-artery bypass surgery. N Engl J Med 1995; 333:1522-1527.
47. Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007:CD005948.
48. Osborn DA, Hunt RW. Postnatal thyroid hormones for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 2007:CD005946.
49. Osborn DA, Hunt RW. Postnatal thyroid hormones for preterm infants with transient hypothyroxinaemia. Cochrane Database Syst Rev 2007:CD005945.
50. Osborn DA. Thyroid hormones for preventing neurodevelopmental impairment in preterm infants. Cochrane Database Syst Rev 2001 :CD001070.
51. Novitzky D, Cooper DK, Barton CI, etal. Triiodothyronine as an inotropic agent after open heart surgery. J Thorac Cardiovasc Surg 1989; 98 (5 Pt 2):972-977; discussion 977-978.
52. Mullis-Jansson SL, Argenziano M, Corwin S, et al. A randomized double-blind study of the effect of triiodothyronine on cardiac function and morbidity after coronary bypass surgery. J Thorac Cardiovasc Surg 1999; 117:1128-1134.
53. Pingitore A, Galli E, Barison A, et al. Acute effects of triiodothyronine (T3) replacement therapy in patients with chronic heart failure and low-T3 syndrome: a randomized, placebo-controlled study. J Clin Endocrinol Metab 2008; 93:1351-1358.
54. Bennett-Guerrero E, Jimenez JL, White WD, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo-controlled trial. Duke T3 study group. JAMA 1996; 275:687-692.
55. Vavouranakis I, Sanoudos G, Manios A, et al. Triiodothyronine administration in coronary artery bypass surgery: effect on hemodynamics. J Cardiovasc Surg (Torino) 1994; 35:383-389.
56. Mainwaring RD, Mirali-Akbar H, Lamberti JJ, Moore JW. Secundum-type atrial septal defects with failure to thrive in the first year of life. J Card Surg 1996; 11:116-120.
57. Bettendorf M, Schmidt KG, Grulich-Henn J, et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000; 356:529-534.
58. Portman MA, Fearneyhough C, Ning XH, et al. Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease. J Thorac Cardiovasc Surg 2000; 120:604-608.
59. Chowdhury D, Ojamaa K, Parnell VA, et al. A prospective randomized clinical study of thyroid hormone treatment after operations for complex congenital heart disease. J Thorac Cardiovasc Surg 2001; 122:1023-1025.
60. Mackie AS, Booth KL, Newburger JW, et al. A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery. J Thorac Cardiovasc Surg 2005; 130:810-816.
61. Dimmick S, Badawi N, Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev 2004:CD004220.
62. Portman MA, Fearneyhough C, Karl TR, et al. The triiodothyronine for infants and children undergoing cardiopulmonary bypass (TRICC) study: design and rationale. Am Heart J 2004; 148:393-398.